UCB (Euronext: UCB) today announced the successful completion of the previously announced transaction to acquire Zogenix (NASDAQ: ZGNX) for US$ 26.00 per share plus a milestone-based contingent value right for a potential cash payment of US$ 2.00 per share. The total transaction is valued at up to approximately US .
/PRNewswire/ UCB (Euronext: UCB) today announced the successful completion of the previously announced transaction to acquire Zogenix (NASDAQ: ZGNX) for US$.
BRUSSELS, Belgium and ATLANTA, March 7, 2022 /PRNewswire/ UCB today announced the successful completion of the previously announced transaction to acquire Zogenix for US$ 26.00 per. | March 7, 2022
/PRNewswire/ UCB (Euronext: UCB) today announced the successful completion of the previously announced transaction to acquire Zogenix (NASDAQ: ZGNX) for US$.